reassurance
As much as I have low faith in the company management, the one thing that reassures me is that the science and intellectual property is worth more than the market cap of 49million. I continue to be greatful for the phase 1b example that showed Ruvidar is effective enough to cure 2 out of 3 patients in one treatment. No immunotherapy drug has that ability.
By way of recap:
the 2 patients cured in the phase 1b had the following profiles.
patient 1
- 12 prior HCG treatment, 2 different tumour locations on the bladder wall.
patient 2
- 18 prior treatments, 3 different tumour locations on the bladder wall.
So the drug had to reach 5 different tumours and ablate them completely. It did so and those patients have stayed NMIBC free ever since.
A drug/device that can do that is worth more than 49 million market cap.
The fact that the share price and working cash flow are the way they are is fully due to management decisions. And so I continue to hold and support the science while remaining disappointed in the management.